<DOC>
	<DOC>NCT00694928</DOC>
	<brief_summary>This study will evaluate the efficacy and safety of a vaginal product compared with that of another vaginal product in the treatment of vaginal infections.</brief_summary>
	<brief_title>Vaginal Infection Study 2</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Butoconazole</mesh_term>
	<criteria>Patients must have a clinical diagnosis of vaginal infection. Patients must be postmenopausal, surgically sterilized or using an acceptable form of birth control. Patients must not have any other infections May not be pregnant or nursing May not be receiving any other antimicrobial therapies or any medications that would interfere with the outcome of the study.</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>